Ultragenyx Pharmaceutical (RARE)
(Delayed Data from NSDQ)
$44.86 USD
-0.20 (-0.44%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $44.83 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: AMC |
6/2024 | $-1.64 | 3.92% |
Earnings Summary
For their last quarter, Ultragenyx Pharmaceutical (RARE) reported earnings of -$2.03 per share, missing the Zacks Consensus Estimate of -$1.72 per share. This reflects a negative earnings surprise of 18.02%. Look out for RARE's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.64 per share, reflecting a year-over-year increase of 27.11%.
Earnings History
Price & Consensus
Zacks News for RARE
Ionis (IONS) Up 6% on Detailed Data From Angelman Drug Study
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services